A forum for researchers, students and applicants in the field of cyclodextrin technology
To establish a method for the orthogonal chemical functionalization of β-cyclodextrin (β-CD)-based polyrotaxane (PRX), unmodified and monoazidated β-CDs (N3-β-CDs) were
Cyclodextrin-based polymers can be prepared starting from the naturally occurring monomers following green and low-cost procedures. They can be selectively
A research team consisting of scientists located in Spain and Denmark have successfully proven that the formation of inclusion complexes
The researchers of College of Medicine (Pennsylvania) and Iowa University have published on ‘Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol
The International conference on Orphan Drugs and Rare Diseases will be taking place during August 8-10, 2022 as a hybrid
Businesswire published: Cyclo Therapeutics Announces Formation of Global Steering Committee Comprised of Leading Experts to Advise on the Global Phase
Over the past two years, the ACTIV programme, run by the US National Institutes of Health (NIH), has included more
The recent work of Jarazo et al. demonstrates that HP-β-CD ameliorates the dopaminergic neuronal loss phenotype, confirming the therapeutic potential
The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as
Traditionally, reversal of neuromuscular blocking agents following the completion of surgery was achieved with cholinesterase inhibitors. Recently, sugammadex has been
